GC MS signs $11.9M OEM deal to supply HbA1c monitoring system to Diasys India

GC MS signed an OEM contract to supply its Greencare A1c fully automated glycated hemoglobin monitoring system to Diasys India. The four-year contract is valued at 13.3 billion won ($11.9 million).

“Under the accord, GC MS will supply 13.3 billion won ($11.9 million) worth of Greencare A1c to Diasys India for four years.”koreabiomed.com

• 1 source
• koreabiomed.comGC MS to supply glycated hemoglobin monitoring system to India < Device/ICT < Article - Korea Biomedical ReviewLee Han-sooJan 28, 2019

Summarized from public sources; check the original articles before acting on it.